PF-07901800 (TTI-621)

TTI-621 · Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-07901800 (TTI-621), covering 2024-05-10 to 2024-05-10. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of PF-07901800 (TTI-621) for Patients With Hematologic Malignancies and Selected Solid Tumors [Phase 1]